Literature DB >> 3431512

Immunostimulating cell surface substance from Staphylococcus epidermidis strain ATCC-31432 prevents metastatic lung colonization in Balb/c-mice.

Y Ohshima1, H L Ko, J Beuth, Y Ichiman, K Yoshida, G Pulverer.   

Abstract

The antineoplastic activity of cell surface substance from Staphylococcus epidermidis ATCC-31432 (CSS-subfraction 2) in mice and its influence on the activation of human leucocytes was studied. After in vitro incubation with CSS-subfraction 2, human polymorphonuclear leucocytes were evidently stimulated. In vivo (Balb/c-mice) intraperitoneal application of subfraction 2 of CSS induced a considerable splenomegaly and greatly increased IgM levels indicating a strong immuno-stimulating activity. In order to evaluate antineoplastic effects of CSS-subfraction 2, we used sarcoma L-1 cells (Balb/c-mouse origin) which cause heavy tumor colonization of the lung. After single systemic injection of subfraction 2 of CSS, the number of lung tumor-cell colonies drastically decreased. The combination of this immunomodulating therapy with a temporary anticoagulation resulted in a further reduction of tumor colonies in the lungs of Balb/c-mice.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3431512     DOI: 10.1007/BF00194888

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  22 in total

1.  Demonstration of fibrin in early stages of experimental metastases.

Authors:  E C Chew; A C Wallace
Journal:  Cancer Res       Date:  1976-06       Impact factor: 12.701

2.  Macrophages and metastasis--a biological approach to cancer therapy.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1985-10       Impact factor: 12.701

3.  Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose.

Authors:  J Beuth; H L Ko; K Oette; G Pulverer; K Roszkowski; G Uhlenbruck
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

4.  Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products.

Authors:  H F Dvorak; N S Orenstein; A C Carvalho; W H Churchill; A M Dvorak; S J Galli; J Feder; A M Bitzer; J Rypysc; P Giovinco
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

5.  Activation of blood coagulation in cancer: Trousseau's syndrome revisited.

Authors:  F R Rickles; R L Edwards
Journal:  Blood       Date:  1983-07       Impact factor: 22.113

6.  Role of NK cells in the antimetastatic effect of anticoagulant drugs.

Authors:  E Gorelik; W W Bere; R B Herberman
Journal:  Int J Cancer       Date:  1984-01-15       Impact factor: 7.396

7.  Relationship between cellular procoagulant activity and metastatic capacity of B16 mouse melanoma variants.

Authors:  L C Gilbert; S G Gordon
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

8.  Characterisation of rat tumour cell hybrids: procoagulant and fibrinolytic activities.

Authors:  P Badenoch-Jones; I A Ramshaw
Journal:  Aust J Exp Biol Med Sci       Date:  1985-02

Review 9.  Inhibition of the arrest of hematogenously disseminated tumor cells.

Authors:  E Tsubura; T Yamashita; S Sone
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

10.  Comparative study on the immunostimulatory potency of different Propionibacterium strains.

Authors:  H L Ko; W Roszkowski; J Jeljaszewicz; G Pulverer
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.